Not So Common Immune Deficiencies

July 27, 2023

Allergies and asthma affect millions of people worldwide. While most cases are due to environmental factors, some people may have underlying immune deficiencies that contribute to their symptoms.

 

Common immunodeficiencies such as allergies and asthma can be treated with lifestyle changes and medications, but rare immunodeficiencies require careful monitoring and treatment to ensure long-term health and well-being.

Multidisciplinary Snot Force Alliance Webcast with Allergist Dr. Lee S. Clore

In May 2023, the Snot Force Assemble! CME webcast delved into the topic of Not So Common Immune Deficiencies, led by Dr. Lee S. Clore, esteemed owner of Allergy and Asthma Specialists, PSC. This case-based event brought together a diverse range of specialists, including otolaryngologists and allergists, to collectively explore the intricacies of managing these unique conditions. Attendees had the opportunity to share and exchange insights on the management and treatment strategies for challenging cases, enhancing their knowledge and expertise in this field.

 

Keep reading to take a look at some of the rare immunodeficiencies that may be related to allergies and asthma and discuss how they can be managed.


Common Variable Immunodeficiency

Common Variable Immunodeficiency (CVID) is a primary disorder characterized by low levels of immunoglobulins in the blood. This condition affects both males and females equally and is typically diagnosed in adulthood. Patients with CVID may experience sinusitis, ear infections, gastrointestinal infections, recurrent infections, autoimmune disorders, allergies, and asthma.

 

The diagnosis and management of CVID require specialized testing and treatment by an experienced immunologist.


Primary Immunodeficiency

Your body's immune system aids in combating infections. Individuals with primary immunodeficiency (PI) have a malfunctioning immune system, which makes them more susceptible to contracting infections and experiencing severe illness as a result.

 

There are over 400 types of PI, which vary in severity. Some individuals may not discover their mild form of PI until adulthood, while others may experience complications from birth or infancy. There is also a more unusual type of PI known as Activated PI3 kinase delta syndrome (APDS).


Activated PI3 Kinase Delta Syndrome (APDS)

This is an uncommon genetic disorder that was recognized as a primary immunodeficiency disease not so long ago. There are two forms of APDS: APDS1 and APDS2, which are both hereditary.

 

The disease disrupts the functioning of the immune system. The primary indications of APDS include recurrent infections in the upper respiratory tract, sinuses, ears, bronchitis, and pneumonia (a lung infection). While most individuals with APDS encounter their initial infection during early childhood, symptoms can appear at any age.

 

Additional symptoms include irritation in the gastrointestinal tract, swelling of lymph nodes, enlargement of the liver and spleen, and an elevated risk of developing lymphoma. Prolonged ear and respiratory tract infections can eventually result in permanent hearing loss and the formation of scar tissue in the lungs, known as bronchiectasis.

 

Treatment for APDS revolves around symptom management, infection prevention, and inflammation reduction.


Treatments

Scientists are making brilliant advancements in developing new treatments for immune deficiencies. Recently, JOENJA® (leniolisib) has been approved by the FDA to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adults and children 12 years of age and older.

 

Other treatments for immune deficiencies include immunoglobulin replacement therapy, bronchodilators, immunomodulatory drugs, and anti-IgE therapy.

 

In this article, we have only touched the surface of the immunodeficiencies related to allergies and asthma. Learn more about immunodeficiencies and other conditions related to the airways from the Snot Force Alliance.

 



Our  webcast series on “Not So Common Immune Deficiency” brought together experts in the field to discuss the latest research and advancements in diagnosing and treating immunodeficiencies. Join the force today to participate in our next meeting and get more insights about such complex disorders. Contact us for more details.

 

Doctor pointing at a nasal scan on a computer monitor
October 27, 2026
What defines treatment failure in chronic rhinosinusitis? Explore refractory sinusitis, SNOT-22, Lund-Kennedy scoring, and personalized CRS treatment.
Doctor and patient reviewing a sinus ct scan beside a medical scan display
October 13, 2026
Learn how ENT doctors can approach complex cases when standard treatment algorithms fall short, using collaboration, research, and personalized airway care.
September 22, 2026
Inflammatory airway diseases can impact a patient's quality of life. Untreated conditions leave patients struggling to breathe, coughing regularly, and feeling unwell for months at a time. Airway disease management has undergone significant changes in recent years. Treating airway diseases has become increasingly complex, despite improvements in methodologies and technologies. In rural and underserved regions, many patients lack access to specialty care. Key Takeaways: Providing high-quality care to patients with airway disease requires collaboration across specialties. It is important to expand rural ENT access and access to multidisciplinary clinics. Clinicians in rural communities can improve patient outcomes through collaborations and with creative solutions that expand airway care. The Need for Multidisciplinary Airway Care Airway diseases affect multiple systems of the body and thus are treated by different types of physicians. Allergists, primary care doctors, pulmonologists, and ENT physicians all play a role in caring for patients with airway conditions. Physicians who can facilitate multidisciplinary care can improve diagnostic accuracy while also helping to ensure better patient outcomes. Challenges in Rural and Underserved Communities Rural ENT access is spotty at best. Many rural areas lack specialty physicians and often, patients must travel long distances to tertiary medical centers where they receive care. As a result, patients with limited transportation options may experience delays in diagnosis and care. Sometimes, these specialty care disparities can leave primary care providers to manage complex airway conditions on their own. In areas where insurance coverage is limited, and referral networks are fragmented, patients may struggle with their conditions without treatment at all. The Consequences of These Limitations Delays in diagnosis and treatment mean poor management of chronic conditions and increased reliance on treatment from acute care settings. Under this system, patients become frustrated as they lean on ineffective treatment methods. Methods for Expanding Access There are many methods for expanding access to patients in rural and underserved areas. Telehealth Airway Care The use of telehealth treatment has significantly expanded in recent years. With telehealth tools, hybrid care models combine in-person and virtual visits. This same technology also connects doctors, bringing together specialists and community clinicians. Regional Centers of Excellence Multidisciplinary airway centers have proven effective for helping patients access specialty care. Airway centers make it easier to streamline referrals in complex cases. These airway centers can serve larger geographic areas by setting up outreach clinics in surrounding communities. Collaborative Networks Partnerships and collaborations between physicians are key to ensuring that primary care providers in underserved areas have access to resources and information. Supporting Rural Physicians There are many ways to support rural physicians. Snot Force has committed to build networks for physicians, helping to ensure the dissemination of information across specialties and practice settings. We facilitate collaboration between disciplines to promote innovation in care for underserved communities. We're bringing doctors together to break down specialty care disparities and improve rural ENT access and information. Our research collaborative depends on many medical professionals to participate, and we're always looking for more physicians to join the force. To learn more, contact Snot Force today .
doctors discussing how AI helps
September 10, 2026
Explore the ethical considerations of AI-guided airway care, including clinical judgment, patient consent, bias, safety, data privacy, and validation.
Unified airway awareness logo
August 25, 2026
Discover how biologics, multidisciplinary care, and precision medicine are shaping the future of unified airway care and chronic airway disease management over the next five years.
anatomy-of-paranasal-sinuses-and-trachea-airway-3d-illustration
August 11, 2026
Explore emerging tools in functional airway assessment, including quantitative CT, airway imaging, airflow modeling, and advanced sinus diagnostics shaping the future of ENT and airway care.
A doctor reviewing a patient chart on a clipboard, representing clinical decision-making for chronic
July 28, 2026
Compare surgery, biologics, and medical management for chronic sinusitis. Learn how clinicians choose the best treatment for CRS and nasal polyps.
Woman in a face mask holding a flower to her nose, illustrating smell loss from chronic sinusitis.
July 16, 2026
Learn why smell loss in chronic sinusitis may signal severe airway disease, nasal polyps, or eosinophilic inflammation, and explore today's treatment options.
doctors training each other
July 7, 2026
Learn why interdisciplinary training in CRS, asthma, biologics, and airway inflammation is essential for preparing clinicians to diagnose and manage complex airway disease.
a group of physicians in a meeting
June 26, 2026
Learn how standardized communication across ENT, allergy, pulmonology, and GI specialties improves care coordination, teamwork, and patient outcomes.